Key Developments: Affymetrix Inc (AFFX.O)

AFFX.O on Nasdaq

10.06USD
26 Dec 2014
Price Change (% chg)

-- (--)
Prev Close
$10.06
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
697,679
52-wk High
$10.14
52-wk Low
$6.25

Search Stocks

Latest Key Developments (Source: Significant Developments)

University of Bristol Collaborates with Affymetrix on Genotyping Arrays for Guaranteed Sustainability of Wheat Production
Monday, 13 Jan 2014 05:00am EST 

Affymetrix Inc:Says that they have collaboratively designed a wheat genotyping array and analyzed data from experiments as part of an effort to understand wheat genetics and breeding with a goal of ensuring guaranteed sustainable production.  Full Article

Affymetrix Inc issues Q4, FY 2013 revenue guidance above analysts' estimates
Tuesday, 7 Jan 2014 06:00am EST 

Affymetrix Inc:Sees Q4 2013 revenue to be approximately $91 million, including a one-time licensing payment of $5.3 million from a diagnostic partner.Sees FY 2013, revenue of approximately $329 million.Revenues of $82.60 million for Q4 2013 and revenues of $320 million for FY 2013 - Thomson Reuters I/B/E/S Estimates.  Full Article

StoneCalibre Acquires Anatrace From Affymetrix Inc
Monday, 14 Oct 2013 09:15am EDT 

StoneCalibre announced that the completion of the acquisition of Anatrace, a part of Affymetrix, Inc. Headquartered in Maumee, Ohio, Anatrace is a developer, manufacturer and global distributor of purity detergents and synthetic lipids for use in membrane protein studies. The terms of the transaction were not disclosed.  Full Article

Affymetrix Inc Appoints Gavin Wood As Executive Vice President And CFO
Monday, 20 May 2013 06:00am EDT 

Affymetrix Inc announced that it has appointed Mr. Gavin Wood to the position of Executive Vice President and Chief Financial Officer (CFO). Tim Barabe, the current CFO, is expected to retire from Affymetrix effective June 28, 2013.  Full Article

Affymetrix Inc Issues Q1 2013 Revenue Guidance Below Analysts' Estimates
Tuesday, 9 Apr 2013 06:00am EDT 

Affymetrix Inc announced that it expects total revenue of approximately $78 million for the first quarter of 2013, including revenue of approximately $19 million from eBioscience. Revenues for the first quarter were below expectations, primarily due to continued headwinds in gene expression business across all regions, in particular Japan. According to I/B/E/S Estimates, analysts on an average are expecting the Company to report revenue of $83 million for the first quarter of 2013.  Full Article

Affymetrix Inc Collaborate With Aqua Gen To Achieve Density View Of Marker Patterns
Tuesday, 19 Mar 2013 06:30am EDT 

Affymetrix Inc announced in collaboration with Aqua Gen, a member of the Erich Wesjohann (EW) Group GmBH and Center for Integrative Genomics (CIGENE) at the Norwegian University of Life Sciences, to genotype more than 900,000 markers per sample from the Atlantic salmon (Salmo salar), thereby achieving the capability to implement genomic selection and improve their salmon breeding program at Aqua Gen. Aqua Gen and CIGENE partnered with Affymetrix to develop the salmon genotyping screening array which consists of 923,627 SNP (Single Nucleotide Polymorphism) markers and includes both diploid and tetraploid sequence variants. The goal of the ongoing study is to identify relevant and polymorphic high resolution markers that can be used downstream for marker trait association studies, genomic selection programs, as well as for a wide variety of applications in genetics and ecology.  Full Article

Affymetrix Inc Issues FY 2013 Revenue Guidance n Line With Analysts' Estimates-Conference Call
Thursday, 14 Feb 2013 03:00pm EST 

Affymetrix Inc announced that outlook for fiscal 2013 is to grow revenue. The Company expect to have revenue in excess of $330 million for fiscal 2013. According to I/B/E/S Estimates, analysts on an average are expecting the Company to report revenue of $332 million for fiscal 2013.  Full Article

Affymetrix Inc Comments On Q1, FY 2013 Charge Guidance
Thursday, 31 Jan 2013 04:00pm EST 

Affymetrix Inc announced that for fiscal 2013, it expects to record a total charge of approximately $7 million, the majority of which will be incurred during the first quarter of 2013 except for $1.8 million which was recognized in fiscal 2012.  Full Article

Affymetrix Inc To Slash 100 Jobs-Reuters
Tuesday, 8 Jan 2013 06:11pm EST 

Reuters reported that Affymetrix Inc will slash more than 100 jobs, or 8% of its workforce, as part of a plan to help it return to profit. Affymetrix said the restructuring is likely to result in annualized savings of about $25 million, and it will take a charge of about $7 million, majority of which will incurred in the first quarter of 2013.  Full Article

Affymetrix Inc Issues Q4, FY 2012 Revenue Guidance In Line With Analysts' Estimates
Tuesday, 8 Jan 2013 05:00pm EST 

Affymetrix Inc announced that for the fourth quarter of 2012, it expects total revenue to be approximately $84 million. For fiscal 2012, it expects total revenue of approximately $295 million. According to I/B/E/S Estimates, analysts on an average are expecting the Company to report revenue of $84 million for the fourth quarter of 2012; revenue of $296 million for fiscal 2012.  Full Article

Search Stocks